Japanese Pharma Stock News

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

The board of Mitsubishi Kakoki Kaisha, Ltd. ( TSE:6331 ) has announced that it will pay a dividend on the 30th of June...

In December 2025, MODEC, Inc. (TSE:6269) was added to the S&P Japan 500 index, marking its inclusion in a major national benchmark. This index addition can materially shape how institutional investors engage with MODEC, as benchmark-tracking funds adjust portfolios to reflect the new constituent. We will examine how MODEC’s inclusion in the S&P Japan 500 could influence its investment narrative and investor engagement going forward. The latest GPUs need a type of rare earth metal called...

Key Insights Chugai Pharmaceutical's significant public companies ownership suggests that the key decisions are...

Key Insights The projected fair value for Artra Group is JP¥221 based on 2 Stage Free Cash Flow to Equity Artra Group's...

Key Insights MTG's significant insider ownership suggests inherent interests in company's expansion Tsuyoshi Matsushita...

Artra Group Corporation ( TSE:6029 ) shares have had a really impressive month, gaining 41% after a shaky period...

The Financial Partners Group Co.,Ltd. ( TSE:7148 ) share price has fared very poorly over the last month, falling by a...

Frontier International Inc. ( TSE:7050 ) recently posted some strong earnings, and the market responded positively. We...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

It is hard to get excited after looking at MITSUI-SOKO HOLDINGS' (TSE:9302) recent performance, when its stock has...

Pola Orbis Holdings (TSE:4927) has wrapped up the liquidation of its majority owned Chinese unit, Orbis Beijing, a planned step in its broader regional restructuring that clarifies where future growth focus might shift. See our latest analysis for Pola Orbis Holdings. Even with the Orbis Beijing exit clarifying its China strategy, Pola Orbis’s recent share price return has stayed weak, with a negative year to date move and three year total shareholder return still firmly in the red. This...

Key Insights The projected fair value for Tokyu is JP¥2,007 based on 2 Stage Free Cash Flow to Equity Current share...

TOPPAN Holdings has already approved a sweeping overhaul of its leadership, appointing Satoshi Oya as President and reshaping executive roles across the group from April 2026, alongside multiple retirements and new officer appointments at TOPPAN Inc. and related subsidiaries. This concentration of corporate planning, technology, AI promotion, and global business development responsibilities in newly elevated leaders could materially influence how TOPPAN executes its transformation in...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

SEIKOH GIKEN's (TSE:6834) stock is up by a considerable 25% over the past three months. Given that the market rewards...

Hyakujushi Bank (TSE:8386) just finalized a sweeping business alliance with Nomura Securities, reshaping how both firms handle asset management and intermediary services. This represents a structural shift investors will want to factor into long term expectations. See our latest analysis for Hyakujushi Bank. That backdrop helps explain why momentum has been so strong, with Hyakujushi Bank’s share price nearly doubling year to date and its five year total shareholder return above 400 percent,...

Wondering if Asahi Group Holdings is quietly turning into a value opportunity while everyone is distracted by flashier names? In this overview, we walk through what the market is pricing in and what the fundamentals suggest it might actually be worth. The stock has slipped about 7% over the last week and 6% over the past month, even though it is still up around 1.9% year to date and 1.6% over the last year, with a stronger 27.9% three year and 29.5% five year performance in the...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...

Shareholders appeared unconcerned with Nihon House Holdings Co., Ltd.'s ( TSE:1873 ) lackluster earnings report last...

NS Solutions Corporation ( TSE:2327 ) shareholders have had their patience rewarded with a 26% share price jump in the...

Key Insights West Japan Railway's significant individual investors ownership suggests that the key decisions are...

Sumitomo Realty & Development (TSE:8830) just doubled down on its India pivot by pairing a 2 for 1 stock split with a long term push into Mumbai rentals, especially high end projects in Bandra Kurla Complex. See our latest analysis for Sumitomo Realty & Development. Those shifts are landing against powerful momentum, with a roughly 63 percent year to date share price return and a 70 percent one year total shareholder return suggesting investors are steadily warming to Sumitomo’s second growth...

Wondering if Astellas Pharma’s strong run still offers value, or if you might be late to the party? This breakdown will help you decide whether the current price still makes sense. The stock has climbed 2.2% over the last week, 9.7% in the past month, and is up 37.5% year to date and 43.0% over the last year, so it is firmly on many investors’ radar. Recent headlines have focused on Astellas expanding its pipeline through strategic partnerships and regulatory milestones for key therapies,...